Recursion Pharmaceuticals Stock Performance
as on August 27, 2026 at 2:15 pm IST
Day's Low
Day's High
$3.43$3.55
1.72%
Downside
1.72%
Upside

52 Week's Low
52 Week's High
$2.77$7.18
20.63%
Downside
105.73%
Upside

Recursion Pharmaceuticals share price movements today
- Previous Close
- $3.56
- Open
- $3.50
- Volume
- 12.1M
- Market Cap
- $1.7B
- Day's Low - High
- $3.43 - $3.55
- 52 Week Low - High
- $2.77 - $7.18
Recursion Pharmaceuticals Historical Returns
- 1 Month Return
- + 18.27 %
- 3 Month Return
- + 12.3 %
- 1 Year Return
- -27.2 %
- 3 Year Return
- -58.26 %
- 5 Year Return
- -84.18 %
Recursion Pharmaceuticals Stock Fundamentals & Key Indicators
Check Recursion Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
-0.9227
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-471.6M
Revenue (TTM)
54.9M
Profit Margin
0.00%
Return On Equity TTM
-56.58%
Recursion Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Recursion Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $1.7B | -84.18% | NA | 0.00% | NA | |
| BUY | $45.3B | 641.42% | NA | 0.00% | NA | |
| BUY | $138.8B | 176.54% | 31.95 | 35.00% | NA | |
| BUY | $55.4B | -58.45% | NA | -141.43% | NA | |
| BUY | $85.3B | 25.67% | 20.62 | 27.87% | 44.39% |
Stock Returns calculator for Recursion Pharmaceuticals Stock including INR - Dollar returns
The Recursion Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Recursion Pharmaceuticals investment value today
Current value as on today
₹77,696
Returns
Returns from Recursion Pharmaceuticals Stock
Dollar Impact
₹6,326 (+6.33%)
Analyst Recommendation on Recursion Pharmaceuticals Stock
Based on 4 analysts
25.00%
Buy
75.00%
Hold
0.00%
Sell
Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Recursion Pharmaceuticals. Average target price of $7.22
Recursion Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Recursion Pharmaceuticals.
What analysts predicted
51.66%UPSIDE
Target Price
$7.22
Current Price
$3.49
Analyzed by
4 Analysts
Target
$7.22
Recursion Pharmaceuticals target price $7.22, a slight upside of 51.66% compared to current price of $3.49. According to 4 analysts rating.
Indian Investors' Interest in Recursion Pharmaceuticals Stock
Investment in Recursion Pharmaceuticals Shares on INDmoney has dropped by -23.04% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Recursion Pharmaceuticals Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Recursion Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Recursion Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Recursion Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Recursion Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Recursion Pharmaceuticals News & Key Events

Today's Timeline - 17 August
Mon, 10:31 AM
-Recursion Pharmaceuticals highlights AI platform advancements, pipeline updates, and collaborations with Roche and Sanofi during a BofA Global Research conference.
Mon, 07:26 PM
-RXRX shares down 22.8% YTD; REC-4881 shows promise in reducing polyp burden, with FDA discussions ongoing for pivotal trial.
Insights on Recursion Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 7 days, RXRX stock has moved up by 4.5%
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 6.47M → 7.67M (in $), with an average increase of 15.6% per quarter
NO EFFECTAgainst Peers

In the last 3 years, Revolution Medicines, Inc. Common Stock has given 33.7% return, outperforming this stock by 92.8%
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 496.3% return, outperforming this stock by 524.9%
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 3 quarters, -108.12M → -131.00M (in $), with an average decrease of 10.1% per quarter
About Recursion Pharmaceuticals
| Organisation | Recursion Pharmaceuticals |
| Headquarters | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
| Industry | Biotechnology |
| CEO | Dr. Najat Khan Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Recursion Pharmaceuticals
Name | Title |
|---|---|
Mr. Benjamin Mabey M.S. | Chief Technology Officer |
Mr. Nathan Hatfield J.D., M.B.A. | Chief Legal Officer & Corporate Secretary |
Mr. Ryan Kelly | Chief Communications Officer |
Ms. Erica Fox | Chief People and Impact Officer |
Mr. Matthew Kinn M.B.A. | Chief Business Officer |
Mr. Sid Jain | Senior Vice President of Clinical Development & Data Science |
Dr. Vicki L. Goodman M.D. | Chief Medical Officer |
Dr. Najat Khan Ph.D. | CEO, President & Director |
Mr. Ben R. Taylor | CFO & President of Recursion UK |
Dr. David Hallett Ph.D. | Chief Scientific Officer |
FAQs
What is Recursion Pharmaceuticals share price today?
Recursion Pharmaceuticals share price today is $3.49 as on at the close of the market. Recursion Pharmaceuticals share today touched a day high of $3.55 and a low of $3.43.
What is the 52 week high and 52 week low for Recursion Pharmaceuticals share?
Recursion Pharmaceuticals share touched a 52 week high of $7.18 on and a 52 week low of $2.77 on . Recursion Pharmaceuticals stock price today i.e. is closed at $3.49,which is 51.39% down from its 52 week high and 25.99% up from its 52 week low.
What is Recursion Pharmaceuticals's market capitalisation today?
Recursion Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Recursion Pharmaceuticals Stock (RXRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Recursion Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Recursion Pharmaceuticals Shares that will get you 0.4298 shares as per Recursion Pharmaceuticals share price of $3.49 per share as on August 27, 2026 at 8:45 am IST.
What is the minimum amount required to buy Recursion Pharmaceuticals Stock (RXRX) from India?
Indian investors can start investing in Recursion Pharmaceuticals (RXRX) shares with as little as ₹95.402 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.02 in Recursion Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Recursion Pharmaceuticals share’s latest price of $3.49 as on August 27, 2026 at 8:45 am IST, you will get 2.8653 shares of Recursion Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Recursion Pharmaceuticals has given to Indian investors in the last 5 years?
Recursion Pharmaceuticals stock has given -84.18% share price returns and 29.12% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?